When angina cannot be cured with stents: what are the remaining options

Facilitators: C. Briguori, D. Dash

Speakers: S. Wlodarczak, H. Rajabali, F. Giannini, E. Gutierrez

Summary

Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.

Presentations available when logged in:

Efficacy of CS reducer in refractory angina pectoris associated with microvascular dysfunction
Effectiveness of coronary sinus reducer implantation in routine clinical practice. 12-month outcomes
Factors influencing successful coronary sinus reducer implantation for refractory angina
Preclinical and first-in-man experience of a next-generation coronary sinus reducer
Efficacy of aspirin in patients with angina without obstructive coronary disease

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

When angina cannot be cured with stents: what are the remaining options

Log in or create account for free